Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients

NCT04437823 is registered in ClinicalTrials.gov with Jinnah Hospital as lead sponsor.

NCT NCT04437823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04437823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients
Lead sponsor
Jinnah Hospital
Phase
Phase 2
Overall status
Completed
Start date
June 1, 2020
Completion date
November 30, 2021
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection